NOTES: Seres Therapeutics: The Banana Stand is on Fire: Seres Therapeutics and the Hubris of a Gut Factory
Flagship Pioneering tried to put a spreadsheet on a gut and burned the banana stand. Seres Therapeutics sold the microbiome future for scrap to Nestlé.
The Banana Stand is on Fire: Seres Therapeutics and the Hubris of a Gut Factory
I’m looking at the numbers for Seres Therapeutics, and the humidity here in Cambridge feels just like that suffocating week in Shinjuku back in 2018. It’s the same feeling of a system about to short-circuit. The same sense of watching an elegant theory get mugged by a messy reality.
This was meant to be the future. Flagship Pioneering, in their infinite wisdom, decided they could industrialise the human gut. They’d build a clean, sterile “Microbiome Factory” to churn out perfect bacterial cures. An Iain M. Banks-style Orbital for your insides.
The market, it seems, disagrees.
***
The Official Story (The Spin)
According to the PowerPoint decks, Seres was "Leading the Microbiome Revolution." They had VOWST, the first FDA-approved oral microbiota therapeutic—a complex cocktail of bacteria grown in a lab to treat nasty gut infections. They were going to standardise the mud, bottle the chaos, and sell it back to us at a premium. Noubar Afeyan, the architect of it all, was promising "extraordinary acceleration."
Yeah, nah. That’s not what happened.
***
The Real Story (The Pulse)
Acceleration looks a lot like driving off a cliff. The whole enterprise is a dog’s breakfast, a perfect case study in corporate hubris meeting the bloody-minded resistance of biology.
* The 99% Collapse: The stock is trading at $7.08. That’s not a dip; it’s a crater. A 99% demolition from its peak. Seres isn’t a pioneer anymore; it’s a $69 million micro-cap zombie, shambling along until someone puts it out of its misery.
* The Catch-22: They’ve paused their main Phase 2 trial because they’re broke. But they need the trial data to get more funding. It’s a perfect, self-eating paradox. It’s the Bluth family logic: you burn down the banana stand for the insurance money, forgetting you lined the walls with the cash.
* The Fire Sale: This is the real kicker. To keep the lights on, they sold the rights to their only approved product, VOWST, to Nestlé. A revolutionary microbiome therapy, the pinnacle of their high-tech factory, sold off to a Swiss food conglomerate. It’s the most Gibson-esque thing I’ve seen all year: the chrome-plated future sold for scrap to the people who make chocolate milk.
***
The Bottom Line
Flagship Pioneering thought they could put a spreadsheet on a gut. They were wrong.
They laid off 30% of their staff and now they’re begging for cash just to finish the trials they already started. This isn’t a “strategic shift.” It’s a liquidation sale with a lab coat.
This is the human cost of that kind of arrogance. The unprotected exposure isn’t just for the patients; it’s for the poor schmucks who bought the story. The factory is shuttered. The banana stand is ash. And there was never any money in it to begin with.
